Muscle wasting: an overview of recent developments in basic research
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
The syndrome of cachexia, i.e., involuntary weight loss in patients with underlying diseases, sarcopenia, i.e., loss of muscle mass due to aging, and general muscle atrophy from disuse and/or prolonged bed rest have received more attention over the last decades. All lead to a higher morbidity and mortality in patients, and therefore, they represent a major socio‐economic burden for the society today. This mini‐review looks at recent developments in basic research that are relevant to the loss of skeletal muscle. It aims to cover the most significant publication of last 3 years on the causes and effects of muscle wasting, new targets for therapy development, and potential biomarkers for assessing skeletal muscle mass. The targets include the following: (1) E‐3 ligases TRIM32, SOCS1, and SOCS3 by involving the elongin BC ubiquitin‐ligase, Cbl‐b, culling 7, Fbxo40, MG53 (TRIM72), and the mitochondrial Mul1; (2) the kinase MST1; and (3) the G‐protein Gαi 2. D(3)‐creatine has the potential to be used as a novel biomarker that allows to monitor actual change in skeletal muscle mass over time. In conclusion, significant development efforts are being made by academic groups as well as numerous pharmaceutical companies to identify new target and biomarker muscles, as muscle wasting represents a great medical need, but no therapies have been approved in the last decades.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lokireddy, S., Wijesoma, I. W., Teng, S., Bonala, S., Gluckman, P. D., McFarlane, C., Sharma, M., & Kambadur, R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.005 · Cited by 154
RetractedSOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904 · cited 1×
“SOCS1 and SOCS3 target IRS-1 in inflammation-induced insulin resistance possibly by involving the elongin BC ubiquitin-ligase [44].”
BackgroundPrevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women
Iannuzzi-Sucich, M., Prestwood, K. M., & Kenny, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.12.m772 · Cited by 890 · cited 2×
“It can thus be estimated that over 3 % of the total world population will be affected by sarcopenia by 2015 [8].”
BackgroundAn overview of sarcopenia: facts and numbers on prevalence and clinical impact
von Haehling, S., Morley, J. E., & Anker, S. D. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0014-2 · Cited by 888
Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models
Schiaffino, S., & Mammucari, C. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-4 · Cited by 816 · cited 3×
“Cytokines like interleukine-1 (IL-1), IL-6, TNF-α, and interferon-γ lead to a receptor-mediated activation of NFκB and FOXO in muscle [32]; the latter can also be activated by glucocorticoids [19].”
BackgroundMitochondrial fission and remodelling contributes to muscle atrophy
Romanello, V., Guadagnin, E., Gomes, L., Roder, I., Sandri, C., Petersen, Y., Milan, G., Masiero, E., Del Piccolo, P., Foretz, M., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.60 · Cited by 596 · cited 1×
“While the UPS is considered to be the major proteolytic pathway responsible for the breakdown of muscle proteins [54], induction of FOXO1/3 by catabolic stimuli has also been linked to mitochondrial dysfunction and a subsequent loss of mitochondria in skeletal muscle contributing to impaired muscle function [55].”
BackgroundSignaling pathways controlling skeletal muscle mass
Egerman, M. A., & Glass, D. J. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.857291 · Cited by 555
Signaling pathways perturbing muscle mass.
Glass, D. J. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833862df · Cited by 359 · cited 3×
“Among others, the glucocorticoid receptor activates REDD1 and KLF15 expression, both inhibiting mTOR activity, KLF15 via BCAT2 gene activation, and it also directly upregulates the expression of MuRF-1 and MAFbx resulting in atrophy [33].”
BackgroundMyostatin/activin pathway antagonism: molecular basis and therapeutic potential
Han, H. Q., Zhou, X., Mitch, W. E., & Goldberg, A. L. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.019 · Cited by 314 · cited 1×
“While the UPS is considered to be the major proteolytic pathway responsible for the breakdown of muscle proteins [54], induction of FOXO1/3 by catabolic stimuli has also been linked to mitochondrial dysfunction and a subsequent loss of mitochondria in skeletal muscle contributing to impaired muscle function [55].”
BackgroundCohen, S., Zhai, B., Gygi, S. P., & Goldberg, A. L. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201110067 · Cited by 205
Cited by
Nutrition, frailty, and sarcopenia
Cruz-Jentoft, A. J., Kiesswetter, E., Drey, M., & Sieber, C. C. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0709-0 · Cited by 488
Biomarkers for physical frailty and sarcopenia: state of the science and future developments
Calvani, R., Marini, F., Cesari, M., Tosato, M., Anker, S. D., von Haehling, S., Miller, R. R., Bernabei, R., Landi, F., Marzetti, E., et al. (2015) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12051 · Cited by 275
Self-citationMitochondrial Activity and Dynamics Changes Regarding Metabolism in Ageing and Obesity
López-Lluch, G. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.12.005 · Cited by 103
“Furthermore, the activity of this ubiquitin ligase has been recently associated with the maintenance of muscle mass (Palus et al., 2014).”
BackgroundMuscle Wasting in Ageing and Chronic Illness
Ebner, N., Sliziuk, V., Scherbakov, N., & Sandek, A. (2015) · ESC Heart Failure · doi:10.1002/ehf2.12033 · Cited by 61
Metadata
- Authors
- Palus, S., von Haehling, S., & Springer, J.
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2014-08-28
- Volume
- 5
- Issue
- 3
- Pages
- 193-198
- ISSN
- 2190-5991 (ISSN-L)
- 2190-6009
- OpenAlex
- W1989726229
- Cited by
- 41
- References
- 14
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Muscle wasting: an overview of recent developments in basic research. https://app.cochat.ai/papers/10.1007/s13539-014-0157-7
- The paper
- Palus, S., von Haehling, S., & Springer, J. (2014). Muscle wasting: an overview of recent developments in basic research. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1007/s13539-014-0157-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.